Diagnostics

New England Biolabs® Announces 2024 Passion in Science Awards® RecipientsNew England Biolabs® Announces 2024 Passion in Science Awards® Recipients

New England Biolabs® Announces 2024 Passion in Science Awards® Recipients

Twelve scientists to be recognized for their inspiring achievements in science mentorship, environmental stewardship, humanitarian efforts and the arts. IPSWICH,…

10 months ago
Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian MarketSequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market

Sequentify and Dexter Collaborate to Introduce Genomic Sequencing Solutions to the Romanian Market

REHOVOT, Israel, Sept. 5, 2024 /PRNewswire/ -- Sequentify has partnered with Dexter, a Romanian distributor, to bring Sequentify's InfiniSeq™ library…

10 months ago
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024

The companies share how their collaboration enables clinical trial enrollment for a novel cancer therapy for oncogene amplified cancers in…

10 months ago
Exer AI Collaborates with Mayo Clinic to Advance Standard of Care for Hand and Wrist Disorders with AIExer AI Collaborates with Mayo Clinic to Advance Standard of Care for Hand and Wrist Disorders with AI

Exer AI Collaborates with Mayo Clinic to Advance Standard of Care for Hand and Wrist Disorders with AI

DENVER, Sept. 5, 2024 /PRNewswire/ -- Exer AI, a clinical AI company addressing musculoskeletal (MSK) and movement disorders, today announced a…

10 months ago
Lexaria Welcomes Industry Veteran as New CEOLexaria Welcomes Industry Veteran as New CEO

Lexaria Welcomes Industry Veteran as New CEO

Outgoing CEO, Chris Bunka, to remain on as Chairman of the Board of Directors and Executive Strategic Advisor KELOWNA, BC…

10 months ago
Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market OpportunitiesZomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities

Zomedica Secures CE Mark for TRUVIEWTM Digital Microscope & Telepathology System, Expanding Global Market Opportunities

CE Mark approval opens European market for TRUVIEW system ANN ARBOR, MI / ACCESSWIRE / September 5, 2024 / Zomedica…

10 months ago
Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®

Spectral AI Awarded Additional Funding from Medical Technology Enterprise Consortium to Support Ongoing Development of DeepView SnapShot M®

Project Funding Exceeds $7.0 MillionDALLAS, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the…

10 months ago
Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine EducationRoyal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education

Royal Society Hosts BioAro’s UK Launch in Partnership with Golden Helix Foundation to Enhance Genomic Medicine Education

NEW YORK, Sept. 4, 2024 /PRNewswire/ -- BioAro successfully launched its presence in the UK at the Royal Society on August 29th,…

10 months ago
Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)

Constantiam Biosciences Secures $2.05M Phase II SBIR Grant from NHGRI to Advance Functional Analysis Platform for Variants of Uncertain Significance (VUS)

HOUSTON, Sept. 4, 2024 /PRNewswire/ -- Constantiam Biosciences, a startup focused on powering genomic medicine, is pleased to announce that…

10 months ago
Biofidelity announces three senior leadership team appointmentsBiofidelity announces three senior leadership team appointments

Biofidelity announces three senior leadership team appointments

Chief Operating Officer, Vice President of People and Chief Financial Officer will contribute to Biofidelity's growth and people priorities CAMBRIDGE,…

10 months ago